LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,340 | -16.3% | 13,000 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $18,330 | -6.0% | 13,000 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $19,500 | +28.2% | 13,000 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $15,210 | +1.4% | 13,000 | 0.0% | 0.00% | -20.0% |
Q3 2022 | $15,000 | -28.6% | 13,000 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $21,000 | +5.0% | 13,000 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $20,000 | -37.5% | 13,000 | 0.0% | 0.01% | -37.5% |
Q4 2021 | $32,000 | -3.0% | 13,000 | 0.0% | 0.01% | -11.1% |
Q3 2021 | $33,000 | -10.8% | 13,000 | 0.0% | 0.01% | -10.0% |
Q2 2021 | $37,000 | +19.4% | 13,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $31,000 | +72.2% | 13,000 | +30.0% | 0.01% | +66.7% |
Q4 2020 | $18,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |